Sign In

Login

Password

Forgot Password ? Sign Up

ADHD (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "ADHD" in Czech language version.

refsWebsite
Global rank Czech rank
41nih.gov
4th place
8th place
36doi.org
2nd place
4th place
34worldcat.org
5th place
3rd place
6web.archive.org
1st place
1st place
5medicalxpress.com
8,255th place
77th place
4psychiatriepropraxi.cz
low place
1,176th place
3youtube.com
9th place
18th place
3wiley.com
222nd place
83rd place
2solen.cz
low place
495th place
2sciencedirect.com
149th place
80th place
2mediately.co
low place
3,963rd place
2seznamzpravy.cz
4,711th place
29th place
2psychiatryonline.org
4,032nd place
4,117th place
1neurologiepropraxi.cz
low place
1,964th place
1who.int
195th place
168th place
1nepozornidospeli.cz
low place
1,202nd place
1russellbarkley.org
low place
low place
1tribune.cz
low place
2,003rd place
1psychiatrie.cz
low place
low place
1irozhlas.cz
3,217th place
16th place
1szm.sk
low place
4,653rd place
1nature.com
234th place
72nd place
1royalsocietypublishing.org
1,993rd place
321st place
1uhk.cz
low place
1,085th place
1psychiatryadvisor.com
low place
low place
1proquest.com
206th place
2,611th place
1bmj.com
1,226th place
800th place
1vitalia.cz
low place
322nd place
1nzip.cz
low place
919th place
1uzis.cz
low place
568th place
1archive.today
14th place
58th place
1mentalhealthdaily.com
low place
4,960th place
1drmax.cz
low place
low place
1aap.org
low place
low place
1sukl.cz
low place
373rd place
1healio.com
low place
low place
1psychscenehub.com
low place
low place
1apa.org
1,220th place
747th place
1frontiersin.org
4,679th place
990th place
1plos.org
2,112th place
284th place
1childmind.org
low place
low place
1psychiatrist.com
low place
low place
1elsevier.com
610th place
203rd place

aap.org (Global: low place; Czech: low place)

publications.aap.org

apa.org (Global: 1,220th place; Czech: 747th place)

psycnet.apa.org

  • APA PsycNet. psycnet.apa.org [online]. [cit. 2024-01-21]. Dostupné online. (anglicky) 

archive.today (Global: 14th place; Czech: 58th place)

bmj.com (Global: 1,226th place; Czech: 800th place)

bmjopen.bmj.com

  • Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review. bmjopen.bmj.com [online]. [cit. 2024-11-22]. Dostupné online. 

childmind.org (Global: low place; Czech: low place)

  • Children and Antipsychotic Medications. Child Mind Institute [online]. [cit. 2025-03-01]. Dostupné online. (anglicky) 

doi.org (Global: 2nd place; Czech: 4th place)

doi.org

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. doi:10.1038/s41588-022-01285-8. (anglicky) 
  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. doi:10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. doi:10.1098/rspb.2022.2584. (anglicky) 
  • EMOND, V.; JOYAL, C.; POISSANT, H. Neuroanatomie structurelle et fonctionnelle du trouble déficitaire d’attention avec ou sans hyperactivité (TDAH). S. 107–114. L'Encéphale [online]. 2009-04. Roč. 35, čís. 2, s. 107–114. Dostupné online. doi:10.1016/j.encep.2008.01.005. (francouzsky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. doi:10.1002/jclp.20121. PMID 15723425. 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. doi:10.1016/j.psyneuen.2017.11.015. (anglicky) 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. doi:10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. doi:10.1002/brb3.330. PMID 25798338. (anglicky) 
  • STÁRKOVÁ, Libuše. ADHD in the light of contenporary psychiatry and clinical practice. Pediatrie pro praxi. 2016-02-01, roč. 17, čís. 1, s. 16–21. Dostupné online [cit. 2024-07-14]. ISSN 1213-0494. doi:10.36290/ped.2016.004. 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. doi:10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. doi:10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • CHANG, Zheng; LICHTENSTEIN, Paul; HALLDNER, Linda. Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry. 2014, roč. 55, čís. 8, s. 878–885. Dostupné online [cit. 2025-02-22]. ISSN 1469-7610. doi:10.1111/jcpp.12164. PMID 25158998. (anglicky) 
  • QUINN, Patrick D.; CHANG, Zheng; HUR, Kwan. ADHD Medication and Substance-Related Problems. American Journal of Psychiatry. 2017-09, roč. 174, čís. 9, s. 877–885. Dostupné online [cit. 2025-02-22]. ISSN 0002-953X. doi:10.1176/appi.ajp.2017.16060686. PMID 28659039. 
  • VERBEECK, Wim; BEKKERING, Geertruida E.; VAN DEN NOORTGATE, Wim. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, roč. 10, čís. 10, s. CD009504. PMID: 28965364 PMCID: PMC6485546. Dostupné online [cit. 2025-04-24]. ISSN 1469-493X. doi:10.1002/14651858.CD009504.pub2. PMID 28965364. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. doi:10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. doi:10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. doi:10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. doi:10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. doi:10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. doi:10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. doi:10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. doi:10.1007/s40263-018-0503-y. PMID 29557078. 
  • OTASOWIE, John; EHIMARE, Umunoibalo; CHALHOUB, Nevyne. Tricyclic antidepressants for ADHD in children and adolescents. Příprava vydání The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd Dostupné online. doi:10.1002/14651858.cd006997. (anglicky) DOI: 10.1002/14651858.CD006997. 
  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. doi:10.1176/jnp.14.3.289. 
  • NAZAROVA, Victoria A.; SOKOLOV, Aleksandr V.; CHUBAREV, Vladimir N. Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology. 2022-11-17, roč. 13. Dostupné online [cit. 2025-03-01]. ISSN 1663-9812. doi:10.3389/fphar.2022.1066988. (anglicky) 
  • CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-03-01]. ISSN 1932-6203. doi:10.1371/journal.pone.0180355. (anglicky) 
  • JH, Loy; SN, Merry; SE, Hetrick. Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane database of systematic reviews. 2017-08-09, roč. 8, čís. 8. PMID: 28791693. Dostupné online [cit. 2025-03-01]. ISSN 1469-493X. doi:10.1002/14651858.CD008559.pub3. PMID 28791693. (anglicky) 
  • NASSER, Azmi; HULL, Joseph T.; CHATURVEDI, Soumya A. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder. CNS drugs. 2022-08, roč. 36, čís. 8, s. 897–915. PMID: 35896943 PMCID: PMC9328182. Dostupné online [cit. 2025-08-03]. ISSN 1179-1934. doi:10.1007/s40263-022-00938-w. PMID 35896943. 
  • FARAONE, Stephen V.; GLATT, Stephen J. A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes. The Journal of Clinical Psychiatry. 2010-06-15, roč. 71, čís. 06, s. 754–763. Dostupné online [cit. 2025-08-03]. ISSN 0160-6689. doi:10.4088/JCP.08m04902pur. 
  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. doi:10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. doi:10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. doi:10.1001/jamanetworkopen.2019.4980. PMID 31150084. 
  • D'ANDREA MEIRA, Isabella; ROMÃO, Tayla Taynan; PIRES DO PRADO, Henrique Jannuzzelli. Ketogenic Diet and Epilepsy: What We Know So Far. Frontiers in Neuroscience. 2019, roč. 13, s. 5. PMID: 30760973 PMCID: PMC6361831. Dostupné online [cit. 2025-04-24]. ISSN 1662-4548. doi:10.3389/fnins.2019.00005. PMID 30760973. 
  • GILLIES, Donna; LEACH, Matthew J.; PEREZ ALGORTA, Guillermo. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane Database of Systematic Reviews. 2023-04-14, roč. 4, čís. 4, s. CD007986. PMID: 37058600 PMCID: PMC10103546. Dostupné online [cit. 2025-03-23]. ISSN 1469-493X. doi:10.1002/14651858.CD007986.pub3. PMID 37058600. 
  • LIAO, Yuhua; XIE, Bo; ZHANG, Huimin. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019-08-05, roč. 9, čís. 1, s. 190. PMID: 31383846 PMCID: PMC6683166. Dostupné online [cit. 2025-03-23]. ISSN 2158-3188. doi:10.1038/s41398-019-0515-5. PMID 31383846. 

dx.doi.org

drmax.cz (Global: low place; Czech: low place)

  • Možnost objednání Vyvanse(Elvanse). Dr. Max lékárna [online]. 2024 [cit. 2024-05-11]. Dostupné online. 

elsevier.com (Global: 610th place; Czech: 203rd place)

linkinghub.elsevier.com

  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. doi:10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 

frontiersin.org (Global: 4,679th place; Czech: 990th place)

  • NAZAROVA, Victoria A.; SOKOLOV, Aleksandr V.; CHUBAREV, Vladimir N. Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology. 2022-11-17, roč. 13. Dostupné online [cit. 2025-03-01]. ISSN 1663-9812. doi:10.3389/fphar.2022.1066988. (anglicky) 

healio.com (Global: low place; Czech: low place)

  • Qelbree improved symptoms, executive function after 1 year in adults with ADHD. www.healio.com [online]. [cit. 2025-04-24]. Dostupné online. (anglicky) 

irozhlas.cz (Global: 3,217th place; Czech: 16th place)

mediately.co (Global: low place; Czech: 3,963rd place)

  • LIVIZUX 30MG: SPC, Složení, Cena. Mediately [online]. [cit. 2025-08-03]. Dostupné online. 
  • ARGOFAN 150MG Tableta s prodlouženým uvolňováním - Databáze léčiv. Mediately [online]. [cit. 2023-03-04]. Dostupné online. 

medicalxpress.com (Global: 8,255th place; Czech: 77th place)

  • Study links child behavior problems to prenatal tobacco smoke and traffic density. medicalxpress.com [online]. 2021-04-27 [cit. 2021-11-05]. Dostupné online. (anglicky) 
  • Half of adults with ADHD have had a substance use disorder. medicalxpress.com [online]. 2021-08-25 [cit. 2021-11-05]. Dostupné online. (anglicky) 
  • Maternal acetaminophen (paracetamol) use may alter placental gene expression, raising ADHD risk in children. medicalxpress.com [online]. [cit. 2025-02-14]. Dostupné online. 
  • Study: Researchers find link between plastic additive and autism, ADHD. medicalxpress.com [online]. [cit. 2023-09-29]. Dostupné online. 
  • More sleep could reduce impulsive behavior in children. medicalxpress.com [online]. [cit. 2023-08-29]. Dostupné online. 

mentalhealthdaily.com (Global: low place; Czech: 4,960th place)

  • Provigil For ADHD: Can Modafinil Help Manage Attention-Deficit Hyperactivity Disorder?. mentalhealthdaily.com [online]. 2014-03-17 [cit. 2021-11-05]. Dostupné online. (anglicky) 

nature.com (Global: 234th place; Czech: 72nd place)

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. doi:10.1038/s41588-022-01285-8. (anglicky) 

nepozornidospeli.cz (Global: low place; Czech: 1,202nd place)

neurologiepropraxi.cz (Global: low place; Czech: 1,964th place)

  • CAHOVÁ, Pavlína; PEJČOCHOVÁ, Jana; OŠLEJŠKOVÁ, Hana. Hyperkinetická porucha/ADHD v dospívání a dospělosti: diagnostika, klinický obraz a komorbidity. S. 373–377. Neurologie pro praxi [online]. 2010. Roč. 11, čís. 6, s. 373–377. Dostupné online. 

nih.gov (Global: 4th place; Czech: 8th place)

ncbi.nlm.nih.gov

  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. doi:10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. doi:10.1002/jclp.20121. PMID 15723425. 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. doi:10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. doi:10.1002/brb3.330. PMID 25798338. (anglicky) 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. doi:10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. doi:10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • CHANG, Zheng; LICHTENSTEIN, Paul; HALLDNER, Linda. Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry. 2014, roč. 55, čís. 8, s. 878–885. Dostupné online [cit. 2025-02-22]. ISSN 1469-7610. doi:10.1111/jcpp.12164. PMID 25158998. (anglicky) 
  • QUINN, Patrick D.; CHANG, Zheng; HUR, Kwan. ADHD Medication and Substance-Related Problems. American Journal of Psychiatry. 2017-09, roč. 174, čís. 9, s. 877–885. Dostupné online [cit. 2025-02-22]. ISSN 0002-953X. doi:10.1176/appi.ajp.2017.16060686. PMID 28659039. 
  • VERBEECK, Wim; BEKKERING, Geertruida E.; VAN DEN NOORTGATE, Wim. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, roč. 10, čís. 10, s. CD009504. PMID: 28965364 PMCID: PMC6485546. Dostupné online [cit. 2025-04-24]. ISSN 1469-493X. doi:10.1002/14651858.CD009504.pub2. PMID 28965364. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. doi:10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. doi:10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. doi:10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. doi:10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. doi:10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. doi:10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. doi:10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. doi:10.1007/s40263-018-0503-y. PMID 29557078. 
  • JH, Loy; SN, Merry; SE, Hetrick. Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane database of systematic reviews. 2017-08-09, roč. 8, čís. 8. PMID: 28791693. Dostupné online [cit. 2025-03-01]. ISSN 1469-493X. doi:10.1002/14651858.CD008559.pub3. PMID 28791693. (anglicky) 
  • NASSER, Azmi; HULL, Joseph T.; CHATURVEDI, Soumya A. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder. CNS drugs. 2022-08, roč. 36, čís. 8, s. 897–915. PMID: 35896943 PMCID: PMC9328182. Dostupné online [cit. 2025-08-03]. ISSN 1179-1934. doi:10.1007/s40263-022-00938-w. PMID 35896943. 
  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. doi:10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. doi:10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. doi:10.1001/jamanetworkopen.2019.4980. PMID 31150084. 
  • D'ANDREA MEIRA, Isabella; ROMÃO, Tayla Taynan; PIRES DO PRADO, Henrique Jannuzzelli. Ketogenic Diet and Epilepsy: What We Know So Far. Frontiers in Neuroscience. 2019, roč. 13, s. 5. PMID: 30760973 PMCID: PMC6361831. Dostupné online [cit. 2025-04-24]. ISSN 1662-4548. doi:10.3389/fnins.2019.00005. PMID 30760973. 
  • GILLIES, Donna; LEACH, Matthew J.; PEREZ ALGORTA, Guillermo. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane Database of Systematic Reviews. 2023-04-14, roč. 4, čís. 4, s. CD007986. PMID: 37058600 PMCID: PMC10103546. Dostupné online [cit. 2025-03-23]. ISSN 1469-493X. doi:10.1002/14651858.CD007986.pub3. PMID 37058600. 
  • LIAO, Yuhua; XIE, Bo; ZHANG, Huimin. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019-08-05, roč. 9, čís. 1, s. 190. PMID: 31383846 PMCID: PMC6683166. Dostupné online [cit. 2025-03-23]. ISSN 2158-3188. doi:10.1038/s41398-019-0515-5. PMID 31383846. 

pubmed.ncbi.nlm.nih.gov

  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. doi:10.1002/jclp.20121. PMID 15723425. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. doi:10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. doi:10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. doi:10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. doi:10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. doi:10.1080/17425255.2019.1675636. PMID 31581854. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. doi:10.1007/s40263-018-0503-y. PMID 29557078. 
  • JH, Loy; SN, Merry; SE, Hetrick. Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane database of systematic reviews. 2017-08-09, roč. 8, čís. 8. PMID: 28791693. Dostupné online [cit. 2025-03-01]. ISSN 1469-493X. doi:10.1002/14651858.CD008559.pub3. PMID 28791693. (anglicky) 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. doi:10.1001/jamanetworkopen.2019.4980. PMID 31150084. 
  • GILLIES, Donna; LEACH, Matthew J.; PEREZ ALGORTA, Guillermo. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane Database of Systematic Reviews. 2023-04-14, roč. 4, čís. 4, s. CD007986. PMID: 37058600 PMCID: PMC10103546. Dostupné online [cit. 2025-03-23]. ISSN 1469-493X. doi:10.1002/14651858.CD007986.pub3. PMID 37058600. 
  • LIAO, Yuhua; XIE, Bo; ZHANG, Huimin. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019-08-05, roč. 9, čís. 1, s. 190. PMID: 31383846 PMCID: PMC6683166. Dostupné online [cit. 2025-03-23]. ISSN 2158-3188. doi:10.1038/s41398-019-0515-5. PMID 31383846. 

pmc.ncbi.nlm.nih.gov

  • VERBEECK, Wim; BEKKERING, Geertruida E.; VAN DEN NOORTGATE, Wim. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, roč. 10, čís. 10, s. CD009504. PMID: 28965364 PMCID: PMC6485546. Dostupné online [cit. 2025-04-24]. ISSN 1469-493X. doi:10.1002/14651858.CD009504.pub2. PMID 28965364. 
  • NASSER, Azmi; HULL, Joseph T.; CHATURVEDI, Soumya A. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder. CNS drugs. 2022-08, roč. 36, čís. 8, s. 897–915. PMID: 35896943 PMCID: PMC9328182. Dostupné online [cit. 2025-08-03]. ISSN 1179-1934. doi:10.1007/s40263-022-00938-w. PMID 35896943. 
  • D'ANDREA MEIRA, Isabella; ROMÃO, Tayla Taynan; PIRES DO PRADO, Henrique Jannuzzelli. Ketogenic Diet and Epilepsy: What We Know So Far. Frontiers in Neuroscience. 2019, roč. 13, s. 5. PMID: 30760973 PMCID: PMC6361831. Dostupné online [cit. 2025-04-24]. ISSN 1662-4548. doi:10.3389/fnins.2019.00005. PMID 30760973. 

nzip.cz (Global: low place; Czech: 919th place)

  • ČR, ÚZIS. ADHD u dětí: příčiny a diagnóza. NZIP.cz [online]. [cit. 2024-02-21]. Dostupné online. 

plos.org (Global: 2,112th place; Czech: 284th place)

journals.plos.org

  • CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-03-01]. ISSN 1932-6203. doi:10.1371/journal.pone.0180355. (anglicky) 

proquest.com (Global: 206th place; Czech: 2,611th place)

  • The Danger of ADHD Overdiagnosis. www.proquest.com [online]. [cit. 2024-11-22]. Dostupné online. 

psychiatrie.cz (Global: low place; Czech: low place)

  • RABOCH, Jiří. Doporučené postupy psychiatrické péče III [online]. Psychiatrická společnost ČLS JEP [cit. 2025-02-22]. S. 262. Obrázek č. 14 Porovnání spotřeby stimulancií v ČR a některých dalších zemích. Dostupné online. 

psychiatriepropraxi.cz (Global: low place; Czech: 1,176th place)

psychiatrist.com (Global: low place; Czech: low place)

  • FARAONE, Stephen V.; GLATT, Stephen J. A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes. The Journal of Clinical Psychiatry. 2010-06-15, roč. 71, čís. 06, s. 754–763. Dostupné online [cit. 2025-08-03]. ISSN 0160-6689. doi:10.4088/JCP.08m04902pur. 

psychiatryadvisor.com (Global: low place; Czech: low place)

  • A True ADHD Epidemic or an Epidemic of Overdiagnosis? [online]. [cit. 2023-10-22]. Dostupné online. 

psychiatryonline.org (Global: 4,032nd place; Czech: 4,117th place)

psychiatryonline.org

neuro.psychiatryonline.org

  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. doi:10.1176/jnp.14.3.289. 

psychscenehub.com (Global: low place; Czech: low place)

  • Psychopharmacology and Clinical Application of Guanfacine and Clonidine for ADHD - What's the Difference?. Psych Scene Hub [online]. 2024-06-27 [cit. 2024-07-20]. Dostupné online. (anglicky) 

royalsocietypublishing.org (Global: 1,993rd place; Czech: 321st place)

  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. doi:10.1098/rspb.2022.2584. (anglicky) 

russellbarkley.org (Global: low place; Czech: low place)

sciencedirect.com (Global: 149th place; Czech: 80th place)

  • EMOND, V.; JOYAL, C.; POISSANT, H. Neuroanatomie structurelle et fonctionnelle du trouble déficitaire d’attention avec ou sans hyperactivité (TDAH). S. 107–114. L'Encéphale [online]. 2009-04. Roč. 35, čís. 2, s. 107–114. Dostupné online. doi:10.1016/j.encep.2008.01.005. (francouzsky) 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. doi:10.1016/j.psyneuen.2017.11.015. (anglicky) 

seznamzpravy.cz (Global: 4,711th place; Czech: 29th place)

  • „Noví pacienti s novými poruchami.“ Systém dětské psychiatrie se hroutí - Seznam Zprávy. www.seznamzpravy.cz [online]. [cit. 2024-02-21]. Dostupné online. 
  • Epidemie deprese v Česku. Třetině deváťáků by prospěla odborná pomoc - Seznam Zprávy. www.seznamzpravy.cz [online]. [cit. 2024-02-21]. Dostupné online. 

solen.cz (Global: low place; Czech: 495th place)

  • MASOPUST ET AL. Diagnostika a farmakoterapie ADHD v dospělosti [online]. Psychiatrie pro praxi, 2014 [cit. 2023-07-30]. Dostupné online. 
  • MASOPUST, Jiří; MOHR, Pavel; ANDERS, Martin. Diagnostika a farmakoterapie ADHD v dospělosti. Psychiatrie pro praxi. 2014-11-01, roč. 15, čís. 3, s. 112–117. Dostupné online [cit. 2024-01-04]. (anglicky) 

sukl.cz (Global: low place; Czech: 373rd place)

szm.sk (Global: low place; Czech: 4,653rd place)

predys.szm.sk

tribune.cz (Global: low place; Czech: 2,003rd place)

  • WWW.BENES-MICHL.CZ, Beneš & Michl. Trendy diagnostiky ADHD: lepší rozpoznání, nebo přehnaná diagnostika? | MT. www.tribune.cz [online]. [cit. 2024-02-21]. Dostupné online. 

uhk.cz (Global: low place; Czech: 1,085th place)

kmen.uhk.cz

uzis.cz (Global: low place; Czech: 568th place)

mkn10.uzis.cz

  • 10. revize Mezinárodní klasifikace nemocí [online]. Praha: Ústav zdravotnických informací a statistiky ČR 2019, 2020-01-01, rev. 2022-01-01 [cit. 2022-05-30]. Kapitola F90 Hyperkinetické poruchy. Dostupné online. 

vitalia.cz (Global: low place; Czech: 322nd place)

  • Blbý spratek, jaképak ADHD. Známý psychiatr o současné výchově dětí. www.vitalia.cz [online]. [cit. 2023-11-22]. Dostupné online. 

web.archive.org (Global: 1st place; Czech: 1st place)

who.int (Global: 195th place; Czech: 168th place)

icd.who.int

  • ICD-11 for Mortality and Morbidity Statistics [online]. [cit. 2024-02-13]. Dostupné online. 

wiley.com (Global: 222nd place; Czech: 83rd place)

onlinelibrary.wiley.com

acamh.onlinelibrary.wiley.com

doi.wiley.com

  • OTASOWIE, John; EHIMARE, Umunoibalo; CHALHOUB, Nevyne. Tricyclic antidepressants for ADHD in children and adolescents. Příprava vydání The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd Dostupné online. doi:10.1002/14651858.cd006997. (anglicky) DOI: 10.1002/14651858.CD006997. 

worldcat.org (Global: 5th place; Czech: 3rd place)

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. doi:10.1038/s41588-022-01285-8. (anglicky) 
  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. doi:10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. doi:10.1098/rspb.2022.2584. (anglicky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. doi:10.1002/jclp.20121. PMID 15723425. 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. doi:10.1016/j.psyneuen.2017.11.015. (anglicky) 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. doi:10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. doi:10.1002/brb3.330. PMID 25798338. (anglicky) 
  • STÁRKOVÁ, Libuše. ADHD in the light of contenporary psychiatry and clinical practice. Pediatrie pro praxi. 2016-02-01, roč. 17, čís. 1, s. 16–21. Dostupné online [cit. 2024-07-14]. ISSN 1213-0494. doi:10.36290/ped.2016.004. 
  • F., Rief, Sandra. Nesoustředěné a neklidné dítě ve škole : praktické postupy pro vyučování a výchovu dětí s ADHD. [s.l.]: Portál Dostupné online. ISBN 80-7178-287-4, ISBN 978-80-7178-287-2. OCLC 43613224 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. doi:10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. doi:10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • CHANG, Zheng; LICHTENSTEIN, Paul; HALLDNER, Linda. Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry. 2014, roč. 55, čís. 8, s. 878–885. Dostupné online [cit. 2025-02-22]. ISSN 1469-7610. doi:10.1111/jcpp.12164. PMID 25158998. (anglicky) 
  • QUINN, Patrick D.; CHANG, Zheng; HUR, Kwan. ADHD Medication and Substance-Related Problems. American Journal of Psychiatry. 2017-09, roč. 174, čís. 9, s. 877–885. Dostupné online [cit. 2025-02-22]. ISSN 0002-953X. doi:10.1176/appi.ajp.2017.16060686. PMID 28659039. 
  • VERBEECK, Wim; BEKKERING, Geertruida E.; VAN DEN NOORTGATE, Wim. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, roč. 10, čís. 10, s. CD009504. PMID: 28965364 PMCID: PMC6485546. Dostupné online [cit. 2025-04-24]. ISSN 1469-493X. doi:10.1002/14651858.CD009504.pub2. PMID 28965364. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. doi:10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. doi:10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. doi:10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. doi:10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. doi:10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. doi:10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. doi:10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. doi:10.1007/s40263-018-0503-y. PMID 29557078. 
  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. doi:10.1176/jnp.14.3.289. 
  • NAZAROVA, Victoria A.; SOKOLOV, Aleksandr V.; CHUBAREV, Vladimir N. Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology. 2022-11-17, roč. 13. Dostupné online [cit. 2025-03-01]. ISSN 1663-9812. doi:10.3389/fphar.2022.1066988. (anglicky) 
  • CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-03-01]. ISSN 1932-6203. doi:10.1371/journal.pone.0180355. (anglicky) 
  • JH, Loy; SN, Merry; SE, Hetrick. Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane database of systematic reviews. 2017-08-09, roč. 8, čís. 8. PMID: 28791693. Dostupné online [cit. 2025-03-01]. ISSN 1469-493X. doi:10.1002/14651858.CD008559.pub3. PMID 28791693. (anglicky) 
  • NASSER, Azmi; HULL, Joseph T.; CHATURVEDI, Soumya A. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder. CNS drugs. 2022-08, roč. 36, čís. 8, s. 897–915. PMID: 35896943 PMCID: PMC9328182. Dostupné online [cit. 2025-08-03]. ISSN 1179-1934. doi:10.1007/s40263-022-00938-w. PMID 35896943. 
  • FARAONE, Stephen V.; GLATT, Stephen J. A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes. The Journal of Clinical Psychiatry. 2010-06-15, roč. 71, čís. 06, s. 754–763. Dostupné online [cit. 2025-08-03]. ISSN 0160-6689. doi:10.4088/JCP.08m04902pur. 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. doi:10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. doi:10.1001/jamanetworkopen.2019.4980. PMID 31150084. 
  • D'ANDREA MEIRA, Isabella; ROMÃO, Tayla Taynan; PIRES DO PRADO, Henrique Jannuzzelli. Ketogenic Diet and Epilepsy: What We Know So Far. Frontiers in Neuroscience. 2019, roč. 13, s. 5. PMID: 30760973 PMCID: PMC6361831. Dostupné online [cit. 2025-04-24]. ISSN 1662-4548. doi:10.3389/fnins.2019.00005. PMID 30760973. 
  • GILLIES, Donna; LEACH, Matthew J.; PEREZ ALGORTA, Guillermo. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane Database of Systematic Reviews. 2023-04-14, roč. 4, čís. 4, s. CD007986. PMID: 37058600 PMCID: PMC10103546. Dostupné online [cit. 2025-03-23]. ISSN 1469-493X. doi:10.1002/14651858.CD007986.pub3. PMID 37058600. 
  • LIAO, Yuhua; XIE, Bo; ZHANG, Huimin. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019-08-05, roč. 9, čís. 1, s. 190. PMID: 31383846 PMCID: PMC6683166. Dostupné online [cit. 2025-03-23]. ISSN 2158-3188. doi:10.1038/s41398-019-0515-5. PMID 31383846. 

youtube.com (Global: 9th place; Czech: 18th place)